Suchergebnisse - "Gerold, Gisa"

PubPharm (8)

1

Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Haid, S. | Matthaei, A. | Winkler, M. | +19

2

Halogenated Rocaglate Derivatives : Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses

enthalten in: Journal of medicinal chemistry | 2024

von Victoria, C. | Schulz, G. | Klöhn, M. | +9

3

Luminescent reporter cells enable the identification of broad-spectrum antivirals against emerging viruses

enthalten in: Journal of medical virology | 2023

von Löw, K. | Möller, R. | Stegmann, C. | +8

4

Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection

enthalten in: PLoS pathogens | 2023

von Mhlekude, B. | Postmus, D. | Stenzel, S. | +19

5

Quantitative Proteomics of Uukuniemi Virus-host Cell Interactions Reveals GBF1 as Proviral Host Factor for Phleboviruses

enthalten in: Molecular & cellular proteomics : MCP | 2019

von Uckeley, Z. | Moeller, R. | Kühn, L. | +14

6

Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan

enthalten in: Journal of virology | 2018

von Fedeli, C. | Torriani, G. | Galan-Navarro, C. | +4

7

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy

enthalten in: Journal of immunology research | 2017

von Bruening, J. | Weigel, B. | Gerold, G.

8

Locking out hepatitis C

enthalten in: Nature medicine | 2011

von Gerold, G. | Rice, C.

CommentOn: Nat Med. 2011 May;17(5):589-95. - PMID 21516087

1
[1]